Mario Tiribelli
Mario Tiribelli
Ricercatore In Ematologia
Verified email at uniud.it
Title
Cited by
Cited by
Year
Contribution of ABL kinase domain mutations to imatinib resistance in different subsets of Philadelphia-positive patients: by the GIMEMA Working Party on Chronic Myeloid Leukemia
S Soverini, S Colarossi, A Gnani, G Rosti, F Castagnetti, A Poerio, ...
Clinical Cancer Research 12 (24), 7374-7379, 2006
5582006
Nilotinib for the frontline treatment of Ph+ chronic myeloid leukemia
G Rosti, F Palandri, F Castagnetti, M Breccia, L Levato, G Gugliotta, ...
Blood, The Journal of the American Society of Hematology 114 (24), 4933-4938, 2009
2582009
The efficacy of imatinib mesylate in patients with FIP1L1-PDGFRα-positive hypereosinophilic syndrome. Results of a multicenter prospective study
M Baccarani, D Cilloni, M Rondoni, E Ottaviani, F Messa, S Merante, ...
haematologica 92 (9), 1173-1179, 2007
2132007
Functional integrity of the p53-mediated apoptotic pathway induced by the nongenotoxic agent nutlin-3 in B-cell chronic lymphocytic leukemia (B-CLL)
P Secchiero, E Barbarotto, M Tiribelli, C Zerbinati, MG Di Iasio, A Gonelli, ...
Blood 107 (10), 4122-4129, 2006
1712006
Inherited thrombocytopenias: a proposed diagnostic algorithm from the Italian Gruppo di Studio delle Piastrine
CL Balduini, M Cattaneo, F Fabris, P Gresele, A Iolascon, FM Pulcinelli, ...
haematologica 88 (5), 582-592, 2003
1332003
The prognostic value of P-glycoprotein (ABCB) and breast cancer resistance protein (ABCG2) in adults with de novo acute myeloid leukemia with normal karyotype
D Damiani, M Tiribelli, E Calistri, A Geromin, A Chiarvesio, A Michelutti, ...
haematologica 91 (6), 825-828, 2006
1212006
Frontline imatinib treatment of chronic myeloid leukemia: no impact of age on outcome, a survey by the GIMEMA CML Working Party
G Gugliotta, F Castagnetti, F Palandri, M Breccia, T Intermesoli, A Capucci, ...
Blood, The Journal of the American Society of Hematology 117 (21), 5591-5599, 2011
1092011
Molecular response to imatinib in late chronic-phase chronic myeloid leukemia
G Rosti, G Martinelli, S Bassi, M Amabile, E Trabacchi, B Giannini, ...
Blood 103 (6), 2284-2290, 2004
1072004
Quantitative assessment of WT1 gene expression after allogeneic stem cell transplantation is a useful tool for monitoring minimal residual disease in acute myeloid …
A Candoni, M Tiribelli, E Toffoletti, D Cilloni, A Chiarvesio, A Michelutti, ...
European journal of haematology 82 (1), 61-68, 2009
1062009
Caspofungin as first line therapy of pulmonary invasive fungal infections in 32 immunocompromised patients with hematologic malignancies
A Candoni, R Mestroni, D Damiani, M Tiribelli, A Michelutti, F Silvestri, ...
European journal of haematology 75 (3), 227-233, 2005
942005
Investigating factors associated with adherence behaviour in patients with chronic myeloid leukemia: an observational patient-centered outcome study
F Efficace, M Baccarani, G Rosti, F Cottone, F Castagnetti, M Breccia, ...
British journal of cancer 107 (6), 904-909, 2012
932012
Nutlin-3 up-regulates the expression of Notch1 in both myeloid and lymphoid leukemic cells, as part of a negative feedback antiapoptotic mechanism
P Secchiero, E Melloni, MG Di Iasio, M Tiribelli, E Rimondi, F Corallini, ...
Blood, The Journal of the American Society of Hematology 113 (18), 4300-4308, 2009
932009
Synergistic cytotoxic activity of recombinant TRAIL plus the non-genotoxic activator of the p53 pathway nutlin-3 in acute myeloid leukemia cells
P Secchiero, C Zerbinati, M Grazia di Iasio, E Melloni, M Tiribelli, V Grill, ...
Current drug metabolism 8 (4), 395-403, 2007
852007
Anti-CD20 therapy for chronic lymphocytic leukemia-associated autoimmune diseases
F Zaja, N Vianelli, A Sperotto, F Patriarca, M Tani, L Marin, M Tiribelli, ...
Leukemia & lymphoma 44 (11), 1951-1955, 2003
802003
Front-line treatment of Philadelphia positive chronic myeloid leukemia with imatinib and interferon-α: 5-year outcome
F Palandri, I Iacobucci, F Castagnetti, N Testoni, A Poerio, M Amabile, ...
haematologica 93 (5), 770-774, 2008
672008
Incidence, risk factors and management of pleural effusions during dasatinib treatment in unselected elderly patients with chronic myelogenous leukaemia
R Latagliata, M Breccia, C Fava, F Stagno, M Tiribelli, L Luciano, ...
Hematological oncology 31 (2), 103-109, 2013
582013
Potential pathogenetic implications of cyclooxygenase-2 overexpression in B chronic lymphoid leukemia cells
P Secchiero, E Barbarotto, A Gonelli, M Tiribelli, C Zerbinati, C Celeghini, ...
The American journal of pathology 167 (6), 1599-1607, 2005
552005
Differences among young adults, adults and elderly chronic myeloid leukemia patients
F Castagnetti, G Gugliotta, M Baccarani, M Breccia, G Specchia, L Levato, ...
Annals of Oncology 26 (1), 185-192, 2015
512015
The MDM-2 antagonist nutlin-3 promotes the maturation of acute myeloid leukemic blasts
P Secchiero, C Zerbinati, E Melloni, D Milani, D Campioni, R Fadda, ...
Neoplasia 9 (10), 853-861, 2007
512007
Testing Sokal's and the new prognostic score for chronic myeloid leukaemia treated with α‐interferon
ITALIAN COOPERATIVE STUDY GROUP ON CHRONIC MYELOID LEUKAEMIA* Writing committee:
British journal of haematology 111 (2), 587-595, 2000
472000
The system can't perform the operation now. Try again later.
Articles 1–20